Xtant Medical Buys Coflex, Cofix Lines From Surgalign for $17 Million

Dow Jones

Mar 01, 2023

By Colin Kellaher

Xtant Medical Holdings Inc. on Wednesday said it has acquired the Coflex and Cofix product lines from fellow medical-technology company Surgalign Holdings Inc. for $17 million.

Xtant, based in Belgrade, Mont., said it expects the products to add about $14 million in annual revenue and help the company achieve profitability in the near future.

The Coflex device is an implant for the treatment of lumbar spinal stenosis, while Cofix is a supplemental fixation device.

Xtant posted revenue of $42.7 million and a loss of $6.3 million for the first nine months of 2022.

Surgalign, based in Deerfield, Ill., said the transaction provides non-dilutive capital that it will use to advance its platform of artificial-intelligence products.

Write to Colin Kellaher at colin.kellaher@wsj.com

(END) Dow Jones Newswires

March 01, 2023 09:44 ET (14:44 GMT)

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2316438096"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2316438096\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2316438096?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-03-01 22:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2316438096","market":"hk","top_or_hot":-1,"title":"Xtant Medical Buys Coflex, Cofix Lines From Surgalign for $17 Million","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/XTNT\">Xtant Medical Holdings Inc</a>. on Wednesday said it has acquired the Coflex and Cofix product lines from fellow medical-technology company Surgalign Holdings Inc. for $17 million. \n</p>\n<p>\n  Xtant, based in Belgrade, Mont., said it expects the products to add about $14 million in annual revenue and help the company achieve profitability in the near future. \n</p>\n<p>\n  The Coflex device is an implant for the treatment of lumbar spinal stenosis, while Cofix is a supplemental fixation device. \n</p>\n<p>\n  Xtant posted revenue of $42.7 million and a loss of $6.3 million for the first nine months of 2022. \n</p>\n<p>\n  Surgalign, based in Deerfield, Ill., said the transaction provides non-dilutive capital that it will use to advance its platform of artificial-intelligence products. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 01, 2023 09:44 ET (14:44 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Xtant Medical Buys Coflex, Cofix Lines From Surgalign for $17 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nXtant Medical Buys Coflex, Cofix Lines From Surgalign for $17 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2023-03-01 22:44</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Colin Kellaher \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/XTNT\">Xtant Medical Holdings Inc</a>. on Wednesday said it has acquired the Coflex and Cofix product lines from fellow medical-technology company Surgalign Holdings Inc. for $17 million. \n</p>\n<p>\n  Xtant, based in Belgrade, Mont., said it expects the products to add about $14 million in annual revenue and help the company achieve profitability in the near future. \n</p>\n<p>\n  The Coflex device is an implant for the treatment of lumbar spinal stenosis, while Cofix is a supplemental fixation device. \n</p>\n<p>\n  Xtant posted revenue of $42.7 million and a loss of $6.3 million for the first nine months of 2022. \n</p>\n<p>\n  Surgalign, based in Deerfield, Ill., said the transaction provides non-dilutive capital that it will use to advance its platform of artificial-intelligence products. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  March 01, 2023 09:44 ET (14:44 GMT)\n</p>\n<p>\n  Copyright (c) 2023 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4198","symbol_name":"医疗保健用品","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2316438096","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2316438096","pubTimestamp":1677681840,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"By Colin Kellaher \n\n\n \n\n\nXtant Medical Holdings Inc. on Wednesday said it has acquired the Coflex an","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4198":"医疗保健用品","XTNT":"Xtant Medical Holdings Inc"},"translate_title":"Xtant Medical以1700万美元从Surgalign收购Coflex和Cofix系列","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"XTNT":1,"SRGA":0.9},"content_text":"By Colin Kellaher \n\n\n \n\n\nXtant Medical Holdings Inc. on Wednesday said it has acquired the Coflex and Cofix product lines from fellow medical-technology company Surgalign Holdings Inc. for $17 million. \n\n\n  Xtant, based in Belgrade, Mont., said it expects the products to add about $14 million in annual revenue and help the company achieve profitability in the near future. \n\n\n  The Coflex device is an implant for the treatment of lumbar spinal stenosis, while Cofix is a supplemental fixation device. \n\n\n  Xtant posted revenue of $42.7 million and a loss of $6.3 million for the first nine months of 2022. \n\n\n  Surgalign, based in Deerfield, Ill., said the transaction provides non-dilutive capital that it will use to advance its platform of artificial-intelligence products. \n\n\n \n\n\n  Write to Colin Kellaher at colin.kellaher@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 01, 2023 09:44 ET (14:44 GMT)\n\n\n  Copyright (c) 2023 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}